RECURSION PHARMACEUTICALS INC. news, videos and press releases - Page 2
For more news please use our advanced search feature.
RECURSION PHARMACEUTICALS INC. - More news...
RECURSION PHARMACEUTICALS INC. - More news...
- Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
- Recursion to Participate in Upcoming Investor Conferences
- Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Recursion to Host Public L(earnings) Call on February 27
- Altitude Lab Startups Raise Over $120M in Capital
- Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
- Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
- Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
- Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
- Bayer and Recursion Focus Research Collaboration on Oncology
- Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology
- Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
- Recursion to Participate in Upcoming Investor Conference
- Recursion to Participate in Upcoming Investor Conferences
- Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
- Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
- Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
- Recursion to Participate in Upcoming Investor Conference
- Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
- Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
- Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
- Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
- Recursion to Participate in Upcoming Investor Conferences
- Altitude Lab Relocates to Gateway’s BioHive Hub
- Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
- Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
